XML 39 R23.htm IDEA: XBRL DOCUMENT v3.25.0.1
Equity
 12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Equity Equity
Shareholders' Equity:

At-The-Market Offering Program. The Company maintains an At-The-Market offering program (“ATM program”) under which the Company can issue common shares, including through forward sales contracts.

The Company may, from time to time, sell up to $350,000 of common shares over the term of the ATM program. During the years ended December 31, 2024 and 2023, the Company did not sell shares under the ATM program. During 2022, the Company issued 3,649,023 common shares, which were previously sold on a forward basis in the first quarter of 2021, on the maturity date of the forward sales contracts and received $38,492 of net proceeds.

Underwritten Equity Offerings. During 2021, the Company entered into forward sales contracts for the sale of 16,000,000 common shares at a public offering price of $12.11 per common share in an underwritten equity offering. The forward sale contracts were settled in December 2022, and the Company received $183,419 of net proceeds. The Company did not issue common shares as part of an underwritten offering in 2024 and 2023.

Stock Based Compensation. During the years ended December 31, 2024, 2023 and 2022, the Company issued 1,669,211, 1,284,704 and 930,602 of its common shares, respectively, to certain employees and trustees. Typically, trustee share grants vest immediately. Employee share grants generally vest ratably, on anniversaries of the grant date, however, in certain situations vesting is cliff-based after a specific number of years and/or subject to meeting certain performance criteria.
Share Repurchase Program. In August 2022, the Company's Board of Trustees authorized the repurchase of up to an additional 10,000,000 common shares under the Company's share repurchase program, which does not have an expiration date. No common shares were repurchased during 2024 and 2023. During 2022, 12,102,074 common shares were repurchased and retired for an average price of $10.78 per share. As of December 31, 2024, 6,874,241 common shares remain available for repurchase under this authorization. The Company records a liability for repurchases that have not yet been settled as of the period end. There were no unsettled repurchases as of December 31, 2024.

Series C Preferred Stock. The Company had 1,935,400 shares of Series C Cumulative Convertible Preferred Stock (“Series C Preferred”) outstanding at December 31, 2024. The shares have a dividend of $3.25 per share per annum and a liquidation preference of $96,770, and the Company, if certain common share prices are achieved, can force conversion into common shares of the Company. As of December 31, 2024, the conversion ratio was one Series C Preferred share to 2.4339 common shares. The conversion rate may increase over time if the Company's common share dividend exceeds certain quarterly thresholds.

If certain fundamental changes occur, holders may require the Company, in certain circumstances, to repurchase all or part of their shares of Series C Preferred. In addition, upon the occurrence of certain fundamental changes, the Company will, under certain circumstances, increase the conversion rate by a number of additional common shares or, in lieu thereof, may in certain circumstances elect to adjust the conversion rate upon the shares of Series C Preferred becoming convertible into shares of the public acquiring or surviving company.

The Company may, at the Company's option, cause shares of Series C Preferred to be automatically converted into that number of common shares that are issuable at the then prevailing conversion rate. The Company may exercise its conversion right only if, at certain times, the closing price of the Company's common shares equals or exceeds 125% of the then prevailing conversion price of the Series C Preferred.
Holders of shares of Series C Preferred generally have no voting rights, but will have limited voting rights if the Company fails to pay dividends for six or more quarters and under certain other circumstances. Upon conversion, the Company may choose to deliver the conversion value to investors in cash, common shares, or a combination of cash and common shares.
A summary of the changes in accumulated other comprehensive income related to the Company's cash flow hedges is as follows:
Years ended December 31,
20242023
Balance at beginning of period$9,483 $17,689 
Other comprehensive income before reclassifications7,802 3,654 
Amounts of (income) reclassified from accumulated other comprehensive income to interest expense(11,149)(11,860)
Balance at end of period$6,136 $9,483 
Noncontrolling Interests. In conjunction with several of the Company's acquisitions in prior years, sellers were issued OP units as a form of consideration. All OP units, other than OP units owned by the Company, were redeemable for common shares at certain times, at the option of the holders, and were generally not otherwise mandatorily redeemable by the Company. The OP units were classified as a component of permanent equity as the Company had determined that the OP units were not redeemable securities as defined by GAAP. Each OP unit was redeemable for approximately 1.13 common shares, subject to future adjustments.

During 2023 and 2022, 832,571 and 39,747 common shares, respectively, were issued by the Company, in connection with OP unit redemptions, for an aggregate book value of $3,393 and $211, respectively. On December 31, 2023, LCIF was merged with and into the Company and all outstanding OP units were converted into 822,627 common shares for a total of $7,800 on a one to 1.13 basis. The Company was the surviving entity of the merger.
The following discloses the effects of changes in the Company's ownership interests in its noncontrolling interests:
Net Income Attributable to Shareholders and Transfers from Noncontrolling Interests
 202420232022
Net income attributable to LXP Industrial Trust shareholders$44,534 $30,383 $113,783 
Transfers from noncontrolling interests:
Increase in additional paid-in-capital for redemption of noncontrolling OP units— 3,393 211 
Change from net income attributable to shareholders and transfers from noncontrolling interests$44,534 $33,776 $113,994